Sensei Biotherapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Sensei Biotherapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q3 2024.
  • Sensei Biotherapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $733K, a 30.1% decline year-over-year.
  • Sensei Biotherapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $3.84M, a 19.6% decline year-over-year.
  • Sensei Biotherapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4.45M, a 23.4% decline from 2022.
  • Sensei Biotherapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.81M, a 2.74% increase from 2021.
  • Sensei Biotherapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.66M, a 279% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $3.84M $733K -$315K -30.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $4.16M $795K -$300K -27.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $4.46M $1.22M +$3K +0.25% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $4.45M $1.1M -$324K -22.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $4.78M $1.05M -$431K -29.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $5.21M $1.1M -$301K -21.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $5.51M $1.21M -$302K -19.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $5.81M $1.42M +$595K +71.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $5.22M $1.48M -$257K -14.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $5.47M $1.4M -$349K -20% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $5.82M $1.52M +$166K +12.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $5.66M $827K +$473K +134% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $5.18M $1.74M +$955K +122% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $4.23M $1.75M +$1.58M +971% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $2.65M $1.35M +$1.16M +595% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $1.49M $354K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $781K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $163K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $194K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.